David Schiff, MD | Neurology | UVA

Dr. David Schiff, MD

Claim this profile

University of Virginia Cancer Center

Studies Glioblastoma
Studies Neurofibromatosis
8 reported clinical trials
21 drugs studied

Area of expertise

1

Glioblastoma

David Schiff, MD has run 4 trials for Glioblastoma. Some of their research focus areas include:

IDH negative
MGMT negative
MGMT positive
2

Neurofibromatosis

David Schiff, MD has run 2 trials for Neurofibromatosis. Some of their research focus areas include:

SMO positive
PTCH1 positive
NF1 positive

Affiliated Hospitals

Image of trial facility.

University Of Virginia Cancer Center

Image of trial facility.

UVA Health, Division Of Neuro-Oncology

Clinical Trials David Schiff, MD is currently running

More about David Schiff, MD

Clinical Trial Related

6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments David Schiff, MD has experience with

  • Temozolomide
  • Obinutuzumab
  • Mirdametinib (PD-0325901)
  • VAL-083
  • Troriluzole
  • VT1021

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does David Schiff, MD specialize in?

Is David Schiff, MD currently recruiting for clinical trials?

Are there any treatments that David Schiff, MD has studied deeply?

What is the best way to schedule an appointment with David Schiff, MD?

What is the office address of David Schiff, MD?

Is there any support for travel costs?